Australia markets closed

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
26.80-0.74 (-2.69%)
As of 09:42AM EDT. Market open.
Show:
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Assets
Current assets
Cash
Cash and cash equivalents
329,633
409,852
98,845
4,479
Total cash
329,633
409,852
98,845
4,479
Net receivables
17,282
12,759
14,648
12,090
Inventory
2,021
2,217
1,237
882.233
Total current assets
353,743
429,594
116,681
18,126
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
19,926
8,756
3,263
2,438
Accumulated depreciation
-3,042
-1,654
-1,203
-909.385
Net property, plant and equipment
16,884
7,102
2,060
1,529
Intangible assets
88,922
-
-
4.167
Other long-term assets
1,715
1,536
135
213.735
Total non-current assets
108,829
9,734
3,065
4,279
Total assets
462,572
439,328
119,746
22,405
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
5,833
-
Accounts payable
2,546
2,098
1,865
1,451
Taxes payable
-
62
79
8.606
Accrued liabilities
4,223
2,181
1,515
706.638
Deferred revenues
0
6,615
-
-
Total current liabilities
24,886
20,876
15,289
6,737
Non-current liabilities
Long-term debt
-
-
19,289
24,500
Deferred tax liabilities
635
-
-
-
Deferred revenues
0
-
-
-
Other long-term liabilities
18,411
-
-
-
Total non-current liabilities
25,946
2,761
19,344
25,737
Total liabilities
50,832
23,637
34,633
32,474
Stockholders' equity
Common stock
25
25
17
46,498
Retained earnings
-93,767
-62,496
-52,212
-57,489
Total stockholders' equity
411,740
415,691
85,113
-10,069
Total liabilities and stockholders' equity
462,572
439,328
119,746
22,405